Prevalence of Chronic Kidney Disease in Tunisian Diabetics

NCT05577650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10145

Last updated 2023-05-10

No results posted yet for this study

Summary

In Tunisia, diabetes is a serious public health problem, its prevalence reaches 22.9% of people aged 18 and over and is likely to affect a quarter of the population by 2045. Diabetic kidney disease is the most common and severe complication of diabetes. It is both a major cause of end-stage renal disease and a risk factor for mortality and cardiovascular morbidity, thus becoming an additional public health concern. Early diagnosis of diabetic kidney disease makes it possible to manage patients more effectively and in a multidisciplinary way, to delay its progression to chronic renal failure.

Conditions

Sponsors & Collaborators

  • Tunisian Society for Nephrology, Dialysis and Renal Transplantation

    collaborator UNKNOWN
  • Dacima Consulting

    lead OTHER

Principal Investigators

  • Labidi Jannet, MD · Military Hospital of Tunis (Tunis, Tunisia)

  • Amel Harzallah, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

  • Awatef Azzabi, MD · University Hospital of Sahloul (Sousse, Tunisia)

  • Badreddine Ben Kaab, MD · La Marsa Internal Security Forces Hospital (Tunis, Tunisia)

  • Ikram Mami, MD · University Hospital of La Rabta (Tunis, Tunisia)

  • Lamia Rais, MD · University Hospital of La Rabta (Tunis, Tunisia)

  • Maissa Hadji Brahim, MD · University Hospital of Taher Sfar (Mahdia, Tunisia)

  • Mouna Hammouda, MD · University Hospital of Fattouma Bourguiba (Monastir, Tunisia)

  • Sahar Agrebi, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

  • Seifeddine Azaiez, MD · Private Clinic (Ben Arous, Tunisia)

  • Soumaya Chargui, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2023-02-12
Completion
2023-02-12

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05577650 on ClinicalTrials.gov